ISN-GSH (insulin-glutathione) is a combination of insulin receptor agonist activity and a reducing agent (glutathione), aimed at improving both insulin signalling and reducing oxidative stress in the brain. The dual approach targets cognition/dementia by protecting neurons from damage caused by oxidative stress and enhancing cellular metabolism through insulin pathways.
Discover our Products
Science-based and high-quality devices
